A phase 2 asthma study of Upstream…
A phase 2 asthma study of Upstream Bio’s TSLP receptor [...]
The FDA specifically took issue…
The FDA specifically took issue with the trial’s control arm, [...]
Nektar Therapeutics is basking in…
Nektar Therapeutics is basking in the honeyed glow of long-term [...]
Evommune has aced its first major…
Evommune has aced its first major test as a public [...]
AstraZeneca is taking its oral…
AstraZeneca is taking its oral GLP-1 drug into phase 3 [...]
Eli Lilly has become the latest…
Eli Lilly has become the latest Big Pharma to buy [...]
Roche has shared the numbers…
Roche has shared the numbers behind its phase 3 win [...]
Eli Lilly is heading back to its…
Eli Lilly is heading back to its regular Chinese collaborator [...]
On top of 348 known job cuts…
On top of 348 known job cuts across the organization [...]
Two dose-limiting toxicities have…
Two dose-limiting toxicities have been recorded in uniQure’s trial evaluating [...]